These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16601712)

  • 1. BIO reaches adolescence.
    Fox JL
    Nat Biotechnol; 2006 Apr; 24(4):381-3. PubMed ID: 16601712
    [No Abstract]   [Full Text] [Related]  

  • 2. Number crunching.
    Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894180
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspective: Why communication in biotechnology is important.
    Gassen HG
    Biotechnol J; 2007 Sep; 2(9):1051-2. PubMed ID: 17768767
    [No Abstract]   [Full Text] [Related]  

  • 4. Future societal issues in industrial biotechnology.
    Schuurbiers D; Osseweijer P; Kinderlerer J
    Biotechnol J; 2007 Sep; 2(9):1112-20. PubMed ID: 17639531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R&I '95 industry forecast. Associations press for strategic alliances.
    Restaurants Inst; 1995 Jan; 105(1):93, 98, 100-1. PubMed ID: 10139746
    [No Abstract]   [Full Text] [Related]  

  • 6. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into US public biotech sector using patenting trends.
    Aggarwal S; Gupta V; Bagchi-Sen S
    Nat Biotechnol; 2006 Jun; 24(6):643-51. PubMed ID: 16763590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The legacy of nuclear risk and the founder effect in biotechnology organizations.
    Fleising U
    Trends Biotechnol; 2002 Apr; 20(4):156-9. PubMed ID: 11906747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing patent strategies: what will they mean for the industry?
    Mills AE; Tereskerz PM
    Nat Biotechnol; 2007 Aug; 25(8):867-8. PubMed ID: 17687359
    [No Abstract]   [Full Text] [Related]  

  • 10. Industrial biotechnology: Current status and future development for the sustainability of human society.
    Zhang W; Bai FW; Zhong JJ
    J Biotechnol; 2009 Oct; 144(1):1-2. PubMed ID: 19874979
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclear medicine technology state of the union.
    Mehlburg L
    J Nucl Med Technol; 2003 Dec; 31(4):190. PubMed ID: 14657283
    [No Abstract]   [Full Text] [Related]  

  • 12. What will replace the tech economy?
    Davis S; Meyer C
    Time; 2000 May; 155(21):76-7. PubMed ID: 11765521
    [No Abstract]   [Full Text] [Related]  

  • 13. Regenerative medicine. The industry comes of age.
    Mason C
    Med Device Technol; 2007; 18(2):25-30. PubMed ID: 17494498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electoral campaign delays resolution of biotech issues.
    Fox JL
    Nat Biotechnol; 2004 Oct; 22(10):1193. PubMed ID: 15470439
    [No Abstract]   [Full Text] [Related]  

  • 15. ImClone's failed culture of expertise.
    Fleising U
    Trends Biotechnol; 2002 Aug; 20(8):326. PubMed ID: 12127277
    [No Abstract]   [Full Text] [Related]  

  • 16. Talking with the public--challenging the public scare.
    Sinemus K
    Biotechnol J; 2007 Sep; 2(9):1047. PubMed ID: 17768765
    [No Abstract]   [Full Text] [Related]  

  • 17. Lee Lynd.
    Lynd L
    Nat Biotechnol; 2011 Mar; 29(3):196. PubMed ID: 21390015
    [No Abstract]   [Full Text] [Related]  

  • 18. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of industrial biotechnology.
    Soetaert W; Vandamme E
    Biotechnol J; 2006; 1(7-8):756-69. PubMed ID: 16897819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethicists race to keep pace with advances in biotechnology.
    Robinson A
    CMAJ; 2002 Aug; 167(3):289. PubMed ID: 12186181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.